ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.

85,013 comparisons

Most participants first33,758 with no events in either group come last101 to 120 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Early Neonatal Death2,409 of 78,360

2,119 of 75,851

0.3 points

0.1 to 0.4

154,211NCT02148952

BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program

Intervention Health Facility Participants vs Control Health Facility Participants: Count of Newborns Returning to Facility for a Health Problem Within 7 Days4,474 of 77,419

4,722 of 75,117

-0.5 points

-0.7 to -0.3

152,536NCT02148952

BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program

Hp Stool Antigen (HpSA)+FIT vs FIT Only: Participation Rate of HpSA + FIT or FIT Only31,497 of 63,508

31,777 of 88,995

13.9 points

13.4 to 14.4

152,503NCT01741363

Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing

Vortioxetine Treatment vs SSRI Treatment: Number of Participants Who Experienced of Intracranial Hemorrhage in Total Follow-up Period2 of 22,827

25 of 124,950

-0.0 points

-0.0 to 0.0

147,777NCT05932407

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of IPD at 3-5 Years of Follow-up59 of 47,501

116 of 98,677

0.0 points

-0.0 to 0.0

146,178NCT05794191

A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of PP at 3-5 Years of Follow-up94 of 47,365

184 of 98,430

0.0 points

-0.0 to 0.1

145,795NCT05794191

A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of ACP at 3-5 Years of Follow-up2,079 of 41,296

4,437 of 86,841

-0.1 points

-0.3 to 0.2

128,137NCT05794191

A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

Standard Texts vs Standard Texts With Transportation Messaging: Number of Participants Vaccinated at the End of the Campaign Period33,357 of 121,743

854 of 3,050

-0.6 points

-2.2 to 1.0

124,793NCT05537441

Precision Vaccine Promotion in Underserved Populations

ACP Video Program vs Usual ACP Procedures: deaths from any cause8,403 of 33,035

17,251 of 70,013

0.8 points

0.2 to 1.4

103,048NCT02612688

Pragmatic Trial of Video Education in Nursing Homes

E-MOTIVE Intervention vs Usual Care: Rate of All Cause Neonatal Mortality Postpartum Until Discharge From the Health Facility2,259 of 49,923

2,233 of 51,535

0.2 points

-0.1 to 0.4

101,458NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

Intervention Group vs Control Group: serious adverse events2,932 of 48,698

2,774 of 52,007

0.7 points

0.4 to 1.0

100,705NCT01084096

Trial of the Use of Antenatal Corticosteroids in Developing Countries

E-MOTIVE Intervention vs Usual Care: Postpartum Maternal Death From Bleeding Until Discharge From the Health Facility12 of 49,101

18 of 50,558

-0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women Receiving Uterine Balloon Tamponade Postpartum Until Discharge From the Health Facility44 of 49,101

57 of 50,558

-0.0 points

-0.1 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women Transferred to a Higher-level Facility Postpartum Until Discharge From the Health Facility85 of 49,101

18 of 50,558

0.1 points

0.1 to 0.2

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Rate of All Cause Maternal Mortality Postpartum Until Discharge From the Health Facility17 of 49,101

28 of 50,558

-0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women Receiving Non-pneumatic Anti-shock Garment (NASG) Postpartum Until Discharge From the Health Facility90 of 49,101

38 of 50,558

0.1 points

0.1 to 0.2

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy With Arterial Ligation Postpartum Until Discharge From the Health Facility0 of 49,101

2 of 50,558

-0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: PPH Treatment by Healthcare Provider up to 2 Hours Postpartum (or up to 24 Hours if Bleeding Continues)5,921 of 49,101

4,899 of 50,558

2.4 points

2.0 to 2.8

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women Receiving a Blood Transfusion Postpartum Until Discharge From the Health Facility1,074 of 49,101

1,296 of 50,558

-0.4 points

-0.6 to -0.2

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women Receiving Blood Transfusion for Postpartum Haemorrhage Until Discharge From the Health Facility580 of 49,101

944 of 50,558

-0.7 points

-0.8 to -0.5

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=6

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02148952-5e61cf31",
        "title": "Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Early Neonatal Death",
        "summary": "2409 of 78360 against 2119 of 75851; risk difference 0.3 points, 95% interval 0.1 to 0.4; NCT02148952, BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program",
        "record": "/library/comparisons/NCT02148952-5e61cf31",
        "nct_id": "NCT02148952",
        "kind": "outcome",
        "participants": 154211,
        "risk_difference": {
          "value": 0.0028063769860080523,
          "lower": 0.0011215599327533505,
          "upper": 0.004490916102906268
        },
        "group_1": "2,409 of 78,360",
        "group_2": "2,119 of 75,851",
        "difference": "0.3 points",
        "interval": "0.1 to 0.4",
        "trial_title": "BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program"
      },
      {
        "id": "NCT02148952-edf23a91",
        "title": "Intervention Health Facility Participants vs Control Health Facility Participants: Count of Newborns Returning to Facility for a Health Problem Within 7 Days",
        "summary": "4474 of 77419 against 4722 of 75117; risk difference -0.5 points, 95% interval -0.7 to -0.3; NCT02148952, BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program",
        "record": "/library/comparisons/NCT02148952-edf23a91",
        "nct_id": "NCT02148952",
        "kind": "outcome",
        "participants": 152536,
        "risk_difference": {
          "value": -0.0050725038459114025,
          "lower": -0.007464479570806629,
          "upper": -0.0026828162491589393
        },
        "group_1": "4,474 of 77,419",
        "group_2": "4,722 of 75,117",
        "difference": "-0.5 points",
        "interval": "-0.7 to -0.3",
        "trial_title": "BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=7",
  "request_id": "kSQ98BQmuzyvWkRc"
}
trial-comparisons-2026-03-23-0.1.0Next page

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?